Inderberg Else Marit相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

化疗耐药肿瘤细胞分泌组增强了三阴性乳腺癌的免疫抑制作用

期刊:Breast Cancer Research

影响因子:5.6

doi:10.1186/s13058-025-02082-x

Skourti Eleni, Seip Kotryna, Mensali Nadia, Jabeen Shakila, Juell Siri, ÃynebrÃ¥ten Inger, Pettersen Solveig, Engebraaten Olav, Corthay Alexandre, Inderberg Else Marit, Dolznig Helmut, MÃ¦landsmo Gunhild Mari, Egeland Eivind Valen, Prasmickaite Lina

发表日期：2025

文献求助收藏

Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study

在一项 1 期研究中，健康受试者接受癌症候选疫苗 FMPV-1/GM-CSF 治疗后，体内产生了移码突变的 TGFβR2 特异性 T 细胞。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-025-03969-6

Inderberg, Else Marit; Singh, Nand; Miller, Robert; Arbe-Barnes, Sarah; Eriksen, Henrik K; Lversen, Berit; Juul, Hedvig Vidarsdotter; Eriksen, Jon Amund; Handeland, Karianne Risberg

细胞生物学

发表日期：2025

文献求助收藏

Emerging Biomarkers for Immunotherapy in Glioblastoma

胶质母细胞瘤免疫治疗的新兴生物标志物

影响因子:4.4

doi:10.3390/cancers14081940

Mensali, Nadia; Inderberg, Else Marit

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)

T-RAD 是一项 I/II 期递增试验设计：利用表达靶向人端粒酶逆转录酶 (hTERT) 的 T 细胞受体的 mRNA 工程化 T 细胞治疗转移性肺癌。

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2022.1031232

Maggadóttir, Sólrún Melkorka; Kvalheim, Gunnar; Wernhoff, Patrik; Sæbøe-Larssen, Stein; Revheim, Mona-Elisabeth; Josefsen, Dag; Wälchli, Sébastien; Helland, Åslaug; Inderberg, Else Marit

细胞生物学

发表日期：2022

文献求助收藏

Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei

靶向突变GNAS的肽疫苗：一种治疗腹膜假性黏液瘤的潜在新方法

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2021-003109

Flatmark, Kjersti; Torgunrud, Annette; Fleten, Karianne G; Davidson, Ben; Juul, Hedvig V; Mensali, Nadia; Lund-Andersen, Christin; Inderberg, Else Marit

发表日期：2021

文献求助收藏

Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors

利用HLA II类限制性T细胞受体靶向KRAS突变治疗实体瘤

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2021.1936757

Dillard, Pierre; Casey, Nicholas; Pollmann, Sylvie; Vernhoff, Patrik; Gaudernack, Gustav; Kvalheim, Gunnar; Wälchli, Sébastien; Inderberg, Else Marit

细胞生物学

免疫/内分泌

发表日期：2021

文献求助收藏

Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer.

循环肿瘤细胞的持续存在与前列腺癌治疗性癌症疫苗的长期临床疗效相关

期刊:Journal of Personalized Medicine

doi:10.3390/jpm11070605

Guldvik Ingrid Jenny, Ekseth Lina, Kishan Amar U, Stensvold Andreas, Inderberg Else Marit, Lilleby Wolfgang

发表日期：2021

文献求助收藏

ISEV2020 Abstract Book

ISEV2020摘要集

期刊:Human Vaccines & Immunotherapeutics

影响因子:3.5

doi:10.1080/21645515.2019.1703456

Inderberg, Else Marit; Wälchli, Sébastien

发表日期：2020

文献求助收藏

NK cells specifically TCR-dressed to kill cancer cells

NK细胞特异性地表达TCR，能够杀死癌细胞

期刊:EBioMedicine

影响因子:10.8

doi:10.1016/j.ebiom.2019.01.031

Mensali, Nadia; Dillard, Pierre; Hebeisen, Michael; Lorenz, Susanne; Theodossiou, Theodossis; Myhre, Marit Renée; Fåne, Anne; Gaudernack, Gustav; Kvalheim, Gunnar; Myklebust, June Helen; Inderberg, Else Marit; Wälchli, Sébastien

细胞生物学

发表日期：2019

文献求助收藏

Chimeric antigen receptor preparation from hybridoma to T-cell expression

从杂交瘤制备嵌合抗原受体到T细胞表达

期刊:Antibody Therapeutics

影响因子:4.5

doi:10.1093/abt/tbz007

Köksal, Hakan; Baken, Elizabeth; Warren, David John; Løset, Geir Åge; Inderberg, Else Marit; Wälchli, Sébastien

细胞生物学

免疫/内分泌

发表日期：2019

文献求助收藏